AZACITIDIN Stada subst sèche 150 mg flac
7680692380029
CH-69238
L01BC07
07.16.1.
Reimbursement limitations:
VIDAZA2
Traitement des patients non éligibles pour une transplantation de cellules souches hématopoïétiques et présentant l’un …
1 / 3
google
Details
- Product number
- 6923802
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- azacitidinum 150 mg, mannitolum, pro vitro.
Articles (1)
Azacitidin Stada 150 mg, Pulver zur Herstellung einer Injektionssuspension
Pulver zur Herstellung einer Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 347.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2024
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 69238
- Drug name
- Azacitidin Stada, Pulver zur Herstellung einer Injektionssuspension
- Galenic form
- PULIS
- ATC Code
- L01BC07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/09/2023
- Authorization expiration date
- 17/09/2028
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AZACITIDIN Stada subst sèche 150 mg flac
- Description (DE)
- AZACITIDIN Stada Trockensub 150 mg Durchstf
- Market launch
- 18/09/2023
- Narcotic (BTM)
- No